What percentage of patients remained on the lowest dose using only 1.8 hrs/day in the Bold clinical study?

In the Bold clinical study, a significant finding was that 50% of patients were able to maintain their treatment regimen on the lowest dose of the medication while using it for only 1.8 hours per day. This indicates that half of the participants were effectively managing their condition with minimal exposure, suggesting both the efficacy of the treatment and the feasibility of such a regimen for long-term use. A percentage this high also underscores the potential advantages of lower dosing frequency or duration, making it a favorable option for patients looking for manageable treatment plans. This finding is crucial in understanding how treatment adherence and effectiveness can be optimized for patient populations in clinical settings.